Ernster L
Department of Biochemistry, Arrhenius Laboratories, Stockholm University, Sweden.
Princess Takamatsu Symp. 1990;21:17-29.
Chemical carcinogenesis is generally recognized as a multistep process consisting of initiation, promotion and progression. Today there is substantial evidence that the process involves reactive species of oxygen, which are generated through enzymic or nonenzymic transformation of xenobiotics and their metabolites, and which can alter nucleic acids, proteins, and lipids, thereby interfering with normal cell growth and differentiation. Most cells possess powerful defense mechanisms against these effects, both in the form of antioxidants acting as free-radical scavengers, and of various enzymes capable of preventing the formation of facilitating the removal of reactive species of oxygen. The present paper is a brief survey of current knowledge concerning these mechanisms. The available information is consistent with the concept that chemical carcinogenesis and its prevention share a common denominator, namely, the metabolic activation of a xenobiotic that can lead, on one hand, to the generation of reactive species of oxygen and thereby cancer initiation, promotion and progression, and, on the other hand, to an induction of antioxidant enzymes that can prevent these effects. The final outcome will depend on the relative impact of the two events. Elucidation of the underlying molecular mechanisms may provide a rationale for devising drugs that enhance resistance against chemical carcinogenesis without themselves being carcinogenic.
化学致癌作用通常被认为是一个多步骤过程,包括启动、促进和进展。如今,有大量证据表明该过程涉及活性氧物种,这些活性氧物种是通过外源性物质及其代谢产物的酶促或非酶促转化产生的,并且能够改变核酸、蛋白质和脂质,从而干扰正常细胞的生长和分化。大多数细胞对这些影响具有强大的防御机制,既有作为自由基清除剂的抗氧化剂形式,也有各种能够防止促进活性氧物种形成或促进其清除的酶。本文是对有关这些机制的当前知识的简要综述。现有信息与以下概念一致,即化学致癌作用及其预防有一个共同的要素,即外源性物质的代谢活化,一方面可导致活性氧物种的产生,从而引发癌症的启动、促进和进展,另一方面可诱导抗氧化酶,从而防止这些影响。最终结果将取决于这两个事件的相对影响。阐明潜在的分子机制可能为设计增强对化学致癌作用的抵抗力且自身无致癌性的药物提供理论依据。